Iron formulations in pediatric practice

Indian Pediatrics

Volumn 41, Issue 8, 2004, Pages 807-815

  Nagpal, Jitender ^a   Choudhury, Panna ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASCORBIC ACID; CARBONYL IRON; CHELATE; DEXORANGE; FERESIS; FERRIC AMMONIUM CITRATE; FERRIC HYDROXIDE; FERRIC ION; FERRIC OXIDE; FERRITIN; FERROUS BISGLYCINATE; FERROUS FUMARATE; FERROUS GLYCINE SULFATE; FERROUS ION; FERROUS SULFATE; FERROX; FEVORIT; FEXID; FEZOCAR; HEMFER A; HEMOGLOBIN; HEMSI; IRON; IRON POLYMALTOSE; OROFER; PLACEBO; RICHFER PLUS; TRIFER; UNCLASSIFIED DRUG;

ADULT; ANEMIA; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER BLOOD LEVEL; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; ZINC BLOOD LEVEL;

ANEMIA, IRON-DEFICIENCY; CHILD, PRESCHOOL; DOSAGE FORMS; HUMANS; INFANT; IRON COMPOUNDS;

EID: 4344688059     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. DeMayer EM, Dallmen P, Gurney JM, Hallberg L, Sood SK, Srikantia SG. Prevention of iron deficiency anaemia. In: Preventing and Controlling Iron Deficiency Anaemia through Primary Health Care. Geneva, World Health Organisation 1989, p. 34-42.
2. Lozoff B, Jimenez E, Wolff AW. Long-term developmental outcome of infants with iron deficiency. New Eng J Med 1991, 325: 687-694.
3. Reports of National Consultation on Control of Nutritional Anemia in India. Ministry of Health and Family Welfare. Government of India, 1998.
4. National Family Health Survey (NFHS-2), India, 1998-99. Mumbai, International Institute for Population Studies and ORC Macro, 2000.
5. Technical consultation on strategies for prevention and control of iron deficiency anaemia amongst under three children in India. Indian Pediatr 2002; 39: 640-647.
6. Hallberg L, Ryttinger L, Solvell L. Side Effects of oral iron therapy. A double blind study of different iron compounds in tablet form. Acta Med Scand Suppl. 1966; 459: 3-10.
7. Preventing iron poisoning in Children. FDA Backgrounder. 1997
8. Piñeda O, Ashmead HD, Perez JM, Lemus CP. Effectiveness of iron amino acid chelate on the treatment of iron deficiency anemia in adolescents. J Appl Nutr 1994; 46: 2-13.
9. Fox TE, Eagles J, Fairweather-Tait SJ. Bioavailability of iron glycine as a fortificant in infant foods. Am J Clin Nutr 1998; 67: 664-668.
10. Bovell-Benjamin AC, Viteri FE, Allen LH. Iron absorption from ferrous bisglycinate and ferric trisglycinate in whole maize is regulated by iron status. Am J Clin Nutr 2000; 71: 1563-1569.
11. Pineda O, Ashmead HD. Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate. Nutrition 2001: 17; 381-384.
12. Aronstam A, Aston DL. A comparative trial of a controlled-release iron tablet preparation ('Ferrocontin' Continus) and ferrous fumarate tablets. Pharmatherapeutica. 1982; 3: 263-267.
13. Lindsay HA. Advantages and Limitations of Iron Amino Acid Chelates as Iron fortificants. Nutr Rev 2002.;60: S18-S21.
14. Marchetti M, Ashmead DM, Tossani N. Comparison of rates of vitamin degradation when mixed with metal sulphates or metal amino acid chelates. J Food Composition Analysis 2000; 13: 875-884.
15. Jeppsen RB. Toxicology and safety of Ferrochel and other iron amino acid chelates. Arch Latinoam Nutr 2001; 51: 26-34.
16. Borbolla JR, Cicero RE, Dibildox MM, Sotres DR, Gutierrez RG. Iron polymaltose complex vs. iron sulphate in the treatment of iron deficiency in infants. Rev Mex Pediatr 2000; 67: 63-67.
17. Geisser P. In vitro studies on interactions of iron salts and complexes with foodstuffs and medicaments. Drug Res 1990; 40: 754.
18. Sozmen EY, Kavakli K, Cetinkaya B, Akcay YD, Yilmaz D, Aydinok Y. Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia. Biol Trace Elem Res 2003; 94: 79-86.
19. Broek C, Curry H, Hanna C, Knipfer M, Taylor L. Adverse effects of iron supplementation: a comparative trial of wax-matrix iron preparation and conventional ferrous sulphate tablets. Clin Ther 1985; 7: 568-573.
20. Langstaff RJ, Geisser P, Heil WG, Bowdler JM. Treatment of iron deficiency anemia: a lower incidence of adverse effects with iron polymaltose complex than ferrous sulfate. Brit J Clin Res 1993; 4: 191-198.
21. Mehta BC. Ineffectiveness of iron polymaltose in treatment of iron deficiency anemia. J Assoc Physicians India 2003; 51: 419-421.
22. Nielsen P, Gubbe EE, Fischer R, Heinrich HC. Bioavailability of iron from ferric polymaltose in humans. Drug Research 1994; 44: 743-748.
23. Fe from neutron activated commercial iron (III) citrate and iron (iii) hydroxide polymaltose in humans. Drug Research 1987; 37: 105-107.
24. Muller A Geisser P. Iron Pharmacokinetics after administration of ferric-hydroxide-polymaltose complexes in rats. Arneim Forsch Drug Res 1984; 34: 1560-1569.
25. Gordeuk VR, Brittenham GM, Bravo J, Hughes MA, Keating LJ. Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion 1990; 30: 239-245.
26. Devasthali SD, Gordeuk VR, Brittenham GM, Bravo JR, Hughes MA, Keating LJ. Bioavailability of carbonyl iron: a randomized, double-blind study. Eur J Haematol 1991; 46: 272-278.
27. Gordeuk VR, Brittenham GM, Hughes M, Keating LJ, Opplt JJ. High-dose carbonyl iron for iron deficiency anemia: a randomized double-blind trial. Am J Clin Nutr 1987; 46: 1029-1034.
28. Gordeuk VR, Brittenham GM, Hughes MA, Keating LJ. Carbonyl iron for short-term supplementation in female blood donors. Transfusion 1987; 27: 80-85.
29. Spiller HA, Wahlen HS, Stephens TL, Krenzelok EP, Benson B, Peterson J, Dellinger JA. Multi-center retrospective evaluation of carbonyl iron ingestions. Vet Hum Toxicol 2002; 44: 28-29.
30. Nenortiene P, Sapragoniene M, Stankevicius A, Matusevicius AP, Daunoras G. Preparation, analysis and anti-anemic action of peroral powders with ferrous oxalate. Ferosol-1. Medicina (Kaunas) 2002; 38: 63-68.
31. Zlotkin S, Arthur P, Antwi KY, Yeung G. Treatment of anemia with microencapsulated ferrous fumarate plus ascorbic acid supplied as sprinkles to complementary (weaning) foods. Am J Clin Nutr 2001; 74: 791-795.
32. Olivares M. Bioavailability of microencapsulated ferrous sulfate in milk. Nutrition 2002; 18: 285-286.
33. Szarfarc SC, de Cassana LM, Fujimori E, Guerra-Shinohara EM, de Oliveira IM. Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women. Arch Latinoam Nutr 2001; 51: 42-47.
34. Jacobs P, Fransman D, Coghlan P. Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors. J Clin Apheresis. 1993; 8: 89-95.